Broad eligibility expansion was too big for some states to handle – like Florida and Missouri – resulting in fewer vaccinated people.
Health
Vaccine hesitancy could threaten herd immunity
Although attitudes have shifted, there remains a stubborn block of people in Maine and elsewhere who won’t get vaccinated against COVID-19.
Medical cannabis studies ramp up, offering hope to some opioid users
Some researchers believe cannabis can help wean prescription opioid users off the addictive and potentially deadly drugs. Others aren’t so sure.
One-shot Johnson & Johnson COVID-19 vaccine in short supply in Maine
State to begin vaccinating housebound residents next week with Johnson & Johnson product.
EU drug regulator finds no overall link between clots, AstraZeneca vaccine
Numerous European countries had suspended use of the vaccine over the last week amid concerns over blood clots in a few dozen of the millions of people vaccinated with the formula across the continent.
State looking for explanations as COVID-19 case counts inch higher
Cases and hospitalizations have been creeping up in the last month, raising concerns about another wave of infections before vaccinations can have an impact.
Many U.S. prison guards refusing vaccine despite COVID-19 outbreaks
Infection rates in prisons are more than 3 times as high as in the general public, and prison staff helped accelerate outbreaks.
Augusta Civic Center vaccination clinic eyeing expanded hours as vaccine supply increases
MaineGeneral Health spokesperson Joy McKenna said the only hindrance to the clinic inoculating more people right now is vaccine supply.
Younger Mainers account for rising number of COVID-19 cases
A modest but steady uptick in cases over the last few weeks appears to be driven in part by Mainers in their 20s and younger.
EU regulator ‘convinced’ AstraZeneca benefit outweighs risk
The European Medicines Agency says thousands of people across the EU develop blood clots every year for a variety of reasons and there was no increased incidents in the clinical studies of the vaccine.